First patient dosed in Qlaris Bio’s phase 2 Nightingale clinical trial for QLS-111
By: Jordana Joy, Associate Editor The study will be evaluating the safety, tolerability, and efficacy of QLS-111 in adult patients with normal tension glaucoma. The first patient has been dosed…